Can't see any prospects from the business fundamental.
The prospects are nicely summarised by the following sentence alone:
“But, that doesn’t mean it can’t continue to provide attractive dividends and perhaps market-beating returns if people are attracted (or required) to have a guaranteed source of earnings in retirement.”
Because annuity-type products currently capture less than 5% of the annual transfer from the accumulation to the retirement phase of Australia’s superannuation system, the room for growth in this business is very substantial, pretty much regardless of where interest rates are.
Add to that the fact that CGF is currently trading at a FY20 PE of 12.3x (vis-a-vis 16.5x for the ASX200) and the fundamental case for Challenger is pretty much made for you.
Cheers
- Forums
- ASX - By Stock
- CGF
- News: CGF Challenger Ltd To Commence U.S. Dollar Annuity Reinsurance
News: CGF Challenger Ltd To Commence U.S. Dollar Annuity Reinsurance, page-57
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGF (ASX) to my watchlist
|
|||||
Last
$7.33 |
Change
0.450(6.54%) |
Mkt cap ! $5.065B |
Open | High | Low | Value | Volume |
$7.34 | $7.57 | $7.11 | $22.56M | 3.072M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1367 | $7.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.35 | 3824 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1367 | 7.310 |
1 | 6622 | 7.300 |
1 | 6622 | 7.280 |
1 | 6622 | 7.260 |
1 | 10000 | 7.250 |
Price($) | Vol. | No. |
---|---|---|
7.350 | 3824 | 2 |
7.370 | 4151 | 3 |
7.400 | 6622 | 1 |
7.420 | 8622 | 2 |
7.430 | 2000 | 1 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
CGF (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online